Answers are grounded in this paper and cite their sources.
Reports successful surgical removal of a superior vena cava and right heart septic thrombus in a patient with Crohn's disease, highlighting catheter risks.
To the Editor: Patients with inflammatory bowel disease (IBD) are at an increased risk for thrombotic events involving both the venous and the arterial districts; this risk has been recognized for a long time and several qualitative and quantitative abnormalities regarding platelets, coagulation cascade, and fibrinolysis have been reported.1,2 There is a link between the localization, extent of involvement, and intensity of inflammatory process and the risk of thrombosis in IBD. Patients with pancolonic involvement and severe active disease are at major risk of thrombus formation.2,3 Probably acquired risk factors play the most relevant role in determining thromboembolic events observed in IBD patients.2 Nutritional support is frequently used in patients with IBD. Short-term central venous catheter for parenteral nutrition is associated with infection, thrombosis, and mechanical complications.4 We can expect a higher risk of thrombosis with the association of these 2 important risk factors. Some cases of IBD patient have been described with thrombosis at unusual sites.1,5,6 We report a case of a 30-year-old woman with pancolonic Crohn's disease (CD) who was admitted to the hospital with severe disease activity (Crohn's Disease Activity Index of 456 points). She had a history of severe anaphylactic reaction to infliximab the previous year. Despite the use of azathioprine 2 mg/kg/day for 5 years, oral prednisone 1.7 mg/kg/day, mesalamine 4 g/day, and metronidazole 20 mg/kg/day for 4 weeks, there was no significant improvement in disease activity. A short-term double-lumen catheter was placed in the right subclavian vein for total parenteral nutrition as a nutritional support and remission therapy. After 17 days the patient presented with 2 episodes of fever and symptomatic hypotension. The chest X-ray was normal and there was no pyuria or bacteriuria at urinalysis. We opted for empirical introduction of vancomycin 20 mg/kg/day, removal of the catheter, and solicitation of quantitative cultures of peripheral blood, of the tip and blood of the catheter. All of them were positive for Staphylococcus epidermidis, with colony formation count (CFC) from catheter blood 10 times greater than colony count from peripheral blood and a quantitative culture of 103 CFC from the catheter tip. Urine culture was negative. Transthoracic echocardiography revealed a large thrombus measuring 3 cm in the longer axis in right atrium and ventricle (Fig. 1). Enoxaparin 2 mg/kg/day was started. After 9 days of vancomycin introduction the patient presented with 2 new febrile episodes and we identified Enterococcus faecalis in 2 peripheral hemocultures of different sites. Rifampin 10 mg/kg/day was introduced. A control transesophagic echocardiography visualized a mobile thrombus within the superior vena cava (SVC) extending to the right atrium and ventricle, measuring 4.5 cm in the longer axis, without complete obstruction of the vein or cardiac valve lesion (Fig. 2). The pulmonary artery and right ventricle were of normal size and there was no pulmonary hypertension. Because of the risk of embolization with percutaneous vascular procedure, the patient was subjected to open-heart surgery with successful removal of the thrombus. No inherited disorders of coagulation were detected after 6 months of oral anticoagulation with warfarin. Transthoracic echocardiography showing a large thrombus measuring 3 cm in the longer axis in right atrium and ventricle. Transesophagic echocardiography visualizing a mobile thrombus within the superior vena cava (SVC) extending to the right atrium and ventricle measuring 4.5 cm in the longer axis. We have to keep in mind that an infected catheter is a differential diagnosis of sepsis, especially the when catheter is used for parenteral nutrition and the patient is immunocompromised.4 However, SVC and right heart thrombosis are exceedingly rare in adults. Only 1 case has been reported in active CD.6 This patient was treated with systemic anticoagulation and antibiotics and was discharged from the hospital on long-term anticoagulant therapy without any invasive procedure. In patients without CD, some patients were treated with open-heart surgery and others with a percutaneous vascular procedure.7,8 In conclusion, our patient is an example of an unusual complication for both IBD and short-term central venous catheter. A high index of suspicion is necessary to avoid delayed diagnosis and poor outcomes in IBD patients with risk factors for thrombosis.
No takes yet. Share an insight, caveat, or question.
Souza et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: